Company
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VE303 | Phase 3 | Clostridium Difficile |
Latest
No recent events.
Follow Vedanta Biosciences, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.